CompletedNCT01663077
Clozapine Blood Levels and Genetic Differences in Schizophrenia
About this title
Read the official source — NCT01663077Medication studyAges 18–65Israel
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Tirat CarmelSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateOctober 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- Tirat Carmel Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Israel
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01663077
- Official title
Show the full official title
Clozapine Fixed Dose Steady State Plasma Levels and the Relationship to the Polymorphism of CYP1A2, CYP3A4, CYP3A5 and CYP2D6 in Clinically Stable Schizophrenic Adult Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tirat Carmel
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tirat Carmel Mental Health Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Clozapine.
Who was this study for?
Listed age limits: 18 years to 65 years.
